Trial Profile
A Single-Centre, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Ascending Study to Evaluate TRC4186 Tablet Formulation in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Aug 2009
Price :
$35
*
At a glance
- Drugs TRC 4186 (Primary)
- Indications Cardiovascular disorders; Diabetic angiopathies
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Torrent Pharmaceuticals
- 01 Sep 2009 Results published in Clinical Drug Investigation.
- 12 Aug 2009 New trial record.